Quantitative Marrow Imaging, Marrow Reserve, And Clinical Outcomes In Patients Undergoing Radiotherapy For Hematologic And Related Disorders

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT07743476
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Clinical Outcomes
  • Hematologic
  • Marrow Reserve
  • Quantitative Marrow Imaging
  • Radiotherapy

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • data collection — OTHER
    The study will collect clinical, imaging, laboratory, treatment, and outcome data from the electronic medical record, radiation treatment planning systems, imaging archives, and other institutional clinical databases

Study Details

To create a registry for people who are undergoing or previously underwent radiotherapy for hematologic or related disorders.

Key Dates

First listed
Aug 4, 2026
Start date
Jan 23, 2027
Status verified
Jul 2026
Primary completion
Dec 31, 2036
Completion
Dec 31, 2038

Study Design

Enrollment
1,000 participants (estimated)

Primary Outcome Measure

Safety and adverse events (AEs). [ Time Frame: Through study completion; an average of 1 year. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UT MD Anderson Cancer CenterHoustonTexas77030
Omran Saifi, MD
[email protected]
832-829-0337
Omran Saifi, MD (SUB_INVESTIGATOR)

Find similar trials in Houston, TX

By research site
UT MD Anderson Cancer Center· Houston, TX

Related Studies